Sharp Clinical delivers exceptional clinical trial services from Phase 1 to commercialization, helping you reduce the time, cost and complexity of your clinical trials.

Our Sharp UK facility, based in South Wales, is our multi-phase clinical services hub that offers support from phase 1 right through to commercialisation, including support for commercial solid oral dose drug packaging.

Sharp has completed its relocation to this $23m state-of-the-art facility to offer our customers greater capacity and an expanded service portfolio, all under one roof.

Our Macungie facility offers the expertise, flexibility and capacity for your pharmaceutical and biotech packaging needs.

Building 4 at our Allentown Campus is our Biotech COE specializing specifically injectables packaging solutions.

Building 1 at our Allentown Campus has 180,000ft2 of Current Good Manufacturing Practice product packaging space.

Our Conshohocken site has been in operation since 1952 and is known for its high-volume blister packaging capability.

Our Belgian site has over 50 years’ experience in pharmaceutical packaging and specializes specifically in injectables packaging.

Our Netherlands sites offer over 4000m2 of packaging space, with potential to double this area within the structure of the existing Heerenveen building.